A. Parr

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

Norman Wolmark, Patrick G Johnston, P. Johnston, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases.

S. Steinberg, S. Cremers, W. Figg, 2005, The Journal of urology.

Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism

Y. Ward, S. Khleif, A. Parr, 2006, Cancer.

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer

S. Steinberg, S. Swain, A. Tan, 2004, Clinical Cancer Research.

Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

S. Steinberg, M. Merino, S. Paik, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

S. Steinberg, E. Kohn, A. Sparreboom, 2006, Cancer biology & therapy.

Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.

S. Steinberg, A. Tan, D. Nguyen, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor.

S. Steinberg, S. Hewitt, S. Swain, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

D. Sargent, P. Johnston, R. Goldberg, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of human anti-thymidine kinase antibodies

C. Allegra, D. Voeller, A. Parr, 2001, Anti-Cancer Drugs.

Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen

T. Myers, S. Holbeck, C. Allegra, 2001, Anti-cancer drugs.